Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?

VOICE — a phase 2B, placebo-controlled, randomized trial testing daily use of an antiretroviral tablet (tenofovir or Truvada) or daily use of tenofovir gel in 5029 women from South Africa, Uganda, and Zimbabwe — found none of the drug regimens effective in reducing HIV-1 acquisition in the intent-to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Behav
Main Authors: Mensch, Barbara S., Brown, Elizabeth R., Liu, Karen, Marrazzo, Jeanne, Chirenje, Zvavahera Mike, Gomez, Kailazarid, Piper, Jeanna, Patterson, Karen, van der Straten, Ariane
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354168/
https://ncbi.nlm.nih.gov/pubmed/26906023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-016-1312-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados